Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001829126-24-003471
Filing Date
2024-05-17
Accepted
2024-05-17 14:56:31
Documents
1
Group Members
LEEN KAWASPROPEL BIO PARTNERS LLCRICHARD KAYNE

Document Format Files

Seq Description Document Type Size
1 SC 13G propelbiomanagement_sc13g.htm SC 13G 162454
  Complete submission text file 0001829126-24-003471.txt   164379
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45969 | Film No.: 24959124
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 11620 WILSHIRE BLVD., SUITE 350 LOS ANGELES CA 90025
Business Address 11620 WILSHIRE BLVD., SUITE 350 LOS ANGELES CA 90025 908-507-9629
Propel Bio Management, LLC (Filed by) CIK: 0001969764 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G